FILING ANALYSIS · MONDAY, NOVEMBER 16
Jaguar Health, Inc. JAGX — 8-K: Results of Operations and Financial Condition
neutral
Jaguar Health reported a reduced net loss of $5.83 million in Q3 2026, with total revenue decreasing 24% year-over-year to $2.34 million, and the company significantly reduced its outstanding debt balance by $10.1 million during the quarter.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →